YI-CHIH LINTAI-SHUAN LAISHUEI-LIONG LINYUNG-MING CHENTZONG-SHINN CHUYU-KANG TU2021-05-132021-05-1320212040-6223https://scholars.lib.ntu.edu.tw/handle/123456789/560793Information on coronavirus disease 2019 (COVID-19) infection in patients with chronic kidney disease (CKD) remains limited. To understand the influence of COVID-19 infection in patients with pre-existing CKD, we conducted a systematic review and meta-analysis to evaluate and compare the risks of all-cause mortality, hospitalization, and critical progression between patients with and without CKD.enCOVID-19; chronic kidney disease; hospitalization; meta-analysis; mortality[SDGs]SDG3all cause mortality; Article; cardiovascular disease; chronic kidney failure; clinical outcome; coronavirus disease 2019; creatinine urine level; critically ill patient; disease exacerbation; endotracheal intubation; hospitalization; human; intensive care unit; meta analysis; outcome assessment; randomized controlled trial (topic); respiratory failure; retrospective study; reverse transcription polymerase chain reaction; risk factor; sepsis; septic shock; systematic reviewjournal article10.1177/2040622321998860337962452-s2.0-85102736859https://api.elsevier.com/content/abstract/scopus_id/85102736859